Elucidation of a protein signature discriminating six common types of adenocarcinoma
Open Access
- 27 December 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (4), 769-775
- https://doi.org/10.1002/ijc.22041
Abstract
Pathologists are commonly facing the problem of attempting to identify the site of origin of a metastatic cancer when no primary tumor has been identified, yet few markers have been identified to date. Multitumor classifiers based on microarray based RNA expression have recently been described. Here we describe the first approximation of a tumor classifier based entirely on protein expression quantified by two-dimensional gel electrophoresis (2DE). The 2DE was used to analyze the proteomic expression pattern of 77 similarly appearing (using histomorphology) adenocarcinomas encompassing 6 types or sites of origin: ovary, colon, kidney, breast, lung and stomach. Discriminating sets of proteins were identified and used to train an artificial neural network (ANN). A leave-one-out cross validation (LOOCV) method was used to test the ability of the constructed network to predict the single held out sample from each iteration with a maximum predictive accuracy of 87% and an average predictive accuracy of 82% over the range of proteins chosen for its construction. These findings demonstrate the use of proteomics to construct a highly accurate ANN-based classifier for the detection of an individual tumor type, as well as distinguishing between 6 common tumor types in an unknown primary diagnosis setting.Keywords
Funding Information
- National Cancer Institute (R21-CA101355, R01-CA098522, K24-CA85429, U01-CA85052)
This publication has 19 references indexed in Scilit:
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Identifying distinct classes of bladder carcinoma using microarraysNature Genetics, 2002
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaThe New England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learningNature Medicine, 2002
- Prediction of central nervous system embryonal tumour outcome based on gene expressionNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classificationProceedings of the National Academy of Sciences of the United States of America, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Treatment of Patients with Cancer of an Unknown Primary SiteThe New England Journal of Medicine, 1993